MSB

2.51%

97.0¢ mesoblast limited

MSB Trading - Aug 2020 on, page-1108

First 1108 Last

Share
Profile

Follow
Austrader9

484 Posts.

35

11/08/20

19:05

Post #: 46463632
Share

Originally posted by sailnyssa: ↑

"The FDA approval this week is now very unlikely..."

Very unlikely? What's the basis for that?
Apart from the fact that no one was expecting a decision from the FDA this week no matter what it thought of the application.
The FDA are doing what they are paid to do -- they are not going to rubber stamp this application or wave it through without asking tough questions.
So what if they are questioning the fact that the phase 3 trial was a single arm study? Or pointing out that the mechanism of action of MSCs is not yet "clearly established". Or that the old trials didn't meet their endpoints? These are all known facts. Nothing new there. Do you think these are points that will have taken the company by surprise? Or that the FDA wasn't aware of these things when they granted priority review?
And what did you expect the FDA to say?
"You know we prefer to have two radomised trials before giving out an approval, but no worries, we are not going to ask any questions about that -- here's your approval, now be on your way."
I think many people convinced themselves that this meeting would be little more than a formality. Well, it's not, but that doesn't mean approval is unlikely.
As for the selloff, it's a massive overraction by people with unrealisic expectations who somehow thought that the obvious questions would not be asked. This has energised the short term & momentum players. The usual well timed but ignorant newspaper pieces have also played their part.
I still believe MSB will have the answers to get through this even if it is on the basis that they have to do a post marketing (phase 4) study.
GLTHA

Expand

But how come a well established stock can go down more than 30% in a single day? It means the fundamentals of this stock are not strong and it was just a bubble like other penny stocks. Just because of one FDA approval this stock reacted so badly that everyone tried to get out. I wonder what happens on Friday if the news is not favorable? Will this company shut down its business? Something needs to be think about.

MSB Price at posting: $3.36 Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

DVP

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

NXG

Cost blow-out for Rook I uranium project sees share plummet for NexGen

GRX

GreenX picks up prospective copper project in Germany

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

MGU

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

WGX

Westgold sets its sights on top five producer status through merger with Karora

VMS

Venture to sniff out high-grade REE targets at Jupiter project, WA

BOE

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

VMT

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Is oil undervalued?

There are more pages in this discussion • 1,277 more messages in this thread...

First 1108 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last 97.0¢		Change -0.025(2.51%)		Mkt cap ! $1.107B

Open	High	Low	Value	Volume
97.0¢	$1.01	96.5¢	$7.757M	7.884M

Buyers (Bids)

No.	Vol.	Price($)
10	274918	97.0¢

Sellers (Offers)

Price($)	Vol.	No.
97.5¢	974	1

View Market Depth

No.	Vol.	Price($)
6	103162	0.970
5	34741	0.965
11	125566	0.960
1	500	0.955
22	165429	0.950

Price($)	Vol.	No.
0.975	974	1
0.990	10204	1
1.000	14000	1
1.010	2877	1
1.015	60000	1

Last trade - 16.10pm 02/08/2024 (20 minute delay)

MSB (ASX) Chart

MSB Trading - Aug 2020 on, page-1108

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Cost blow-out for Rook I uranium project sees share plummet for NexGen

GreenX picks up prospective copper project in Germany

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Westgold sets its sights on top five producer status through merger with Karora

Venture to sniff out high-grade REE targets at Jupiter project, WA

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Is oil undervalued?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

MSB Trading - Aug 2020 on, page-1108

Top Stories

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Cost blow-out for Rook I uranium project sees share plummet for NexGen

GreenX picks up prospective copper project in Germany

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Westgold sets its sights on top five producer status through merger with Karora

Venture to sniff out high-grade REE targets at Jupiter project, WA

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Is oil undervalued?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News